# Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients

> **NCT06194617** · — · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Pulmonary Embolism
- Venous Thromboembolism
- Anticoagulant-induced Bleeding

## Interventions

- **DRUG:** Direct oral anticoagulant

## Key facts

- **NCT ID:** NCT06194617
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06194617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06194617, "Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06194617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*